D. E. Shaw & Co. Inc. Grows Position in Avanos Medical, Inc. (NYSE:AVNS)

D. E. Shaw & Co. Inc. boosted its stake in shares of Avanos Medical, Inc. (NYSE:AVNS) by 43.1% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 494,627 shares of the company’s stock after purchasing an additional 148,902 shares during the period. D. E. Shaw & Co. Inc.’s holdings in Avanos Medical were worth $7,874,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also bought and sold shares of the business. Illinois Municipal Retirement Fund boosted its holdings in Avanos Medical by 3.1% during the fourth quarter. Illinois Municipal Retirement Fund now owns 25,236 shares of the company’s stock worth $402,000 after buying an additional 748 shares in the last quarter. Comerica Bank raised its position in shares of Avanos Medical by 3.4% in the fourth quarter. Comerica Bank now owns 22,903 shares of the company’s stock valued at $365,000 after buying an additional 755 shares during the last quarter. EP Wealth Advisors LLC raised its position in shares of Avanos Medical by 14.6% in the fourth quarter. EP Wealth Advisors LLC now owns 10,108 shares of the company’s stock valued at $161,000 after buying an additional 1,289 shares during the last quarter. Bank of America Corp DE raised its position in shares of Avanos Medical by 2.5% in the fourth quarter. Bank of America Corp DE now owns 63,672 shares of the company’s stock valued at $1,014,000 after buying an additional 1,537 shares during the last quarter. Finally, Mariner LLC increased its position in Avanos Medical by 18.0% during the fourth quarter. Mariner LLC now owns 10,655 shares of the company’s stock worth $170,000 after purchasing an additional 1,625 shares during the last quarter. 95.17% of the stock is currently owned by institutional investors and hedge funds.

Avanos Medical Stock Up 4.9%

Shares of Avanos Medical stock opened at $12.75 on Friday. Avanos Medical, Inc. has a 52-week low of $11.84 and a 52-week high of $25.36. The company has a 50 day moving average of $13.23 and a 200 day moving average of $15.81. The company has a quick ratio of 1.46, a current ratio of 2.22 and a debt-to-equity ratio of 0.12. The company has a market capitalization of $589.61 million, a P/E ratio of 37.50 and a beta of 1.13.

Avanos Medical (NYSE:AVNS) last issued its quarterly earnings results on Tuesday, May 6th. The company reported $0.26 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.19 by $0.07. Avanos Medical had a net margin of 2.30% and a return on equity of 4.70%. The company had revenue of $167.50 million during the quarter, compared to the consensus estimate of $161.75 million. During the same quarter in the previous year, the firm earned $0.22 earnings per share. The firm’s quarterly revenue was up .8% on a year-over-year basis. As a group, research analysts forecast that Avanos Medical, Inc. will post 1.32 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Separately, StockNews.com raised shares of Avanos Medical from a “hold” rating to a “buy” rating in a research note on Wednesday, March 19th.

Insider Activity

In other Avanos Medical news, SVP Kerr Holbrook sold 7,000 shares of the business’s stock in a transaction on Thursday, March 6th. The shares were sold at an average price of $15.25, for a total transaction of $106,750.00. Following the sale, the senior vice president now directly owns 82,047 shares in the company, valued at approximately $1,251,216.75. The trade was a 7.86% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 2.64% of the company’s stock.

Avanos Medical Company Profile

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.